Off-Label Uses of CA Drugs Reviewed in AHRQ Report

posted on Jun 01 by in the Uncategorized category Physicians seeking justification for off-label uses of targeted cancer therapies may find it in a new report sponsored by the Agency for Healthcare Research and Quality (AHRQ).

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes